Press Releases Bayer AG Deutsche Boerse AG

Equities

BAYN

DE000BAY0017

Real-time Estimate Tradegate Other stock markets 10:25:00 2024-07-17 am EDT			5-day change	1st Jan Change
26.68 ^EUR	+2.14%		+0.61%	-22.24%

01:51pm	BAYER AG : JP Morgan remains Neutral	ZD
11:34am	Bayer: new positive data for Nubeqa	CF

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bayer AG - AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson's disease	Jul. 12	AQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jun. 26	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jun. 20	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 23	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 22	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 21	EQ
Bayer : Q1 Media Update	May. 14	PU
Bayer : First-quarter performance as expected	May. 14	PU
Bayer : Debt Investor Information FY 2023 / Q1 2024 (DE)	May. 13	PU
Bayer : Debt Investor Information FY 2023 Q1 204	May. 13	PU
Bayer : Quarterly Statement First Quarter 2024	May. 13	PU
Bayer : Address by Bill Anderson	Apr. 26	PU
Bayer : Address by Bill Anderson	Apr. 22	PU
Bayer : Explanations to the Supervisory Board Report - Prof. Dr. Norbert Winkeljohann	Apr. 22	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 17	EQ
Bayer - AskBio Names Mansuo Shannon Chief Scientific Officer	Apr. 10	AQ
Bayer and Vividion Therapeutics to highlight advancing oncology portfolio at AACR 2024 Annual Meeting	Apr. 04	AQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 03	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Mar. 27	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Mar. 22	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BAYER : As soft as anticipated

May 14, 2024 at 02:12 pm EDT

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am EST